THE ROCK — Class I drug recall D-0158-2024
Ongoing recall by Noah's Wholesale LLC, reported 2023-12-27, distributed in FL. Marketed Without an Approved NDA/ANDA: FDA analysis found the product to be tainted with Sildenafil an ingredi
| Recall number | D-0158-2024 |
|---|---|
| Product type | Drug |
| Classification | Class I |
| Status | Ongoing |
| Voluntary or mandated | Voluntary |
| Recalling firm | Noah's Wholesale LLC, Miami Lakes, FL, United States |
| Recall initiated | 2023-10-16 |
| Classified | 2023-12-21 |
| Reported by FDA | 2023-12-27 |
| Distributed | FL |
| Countries outside the US | BS |
| Quantity | 173 capsules |
| Reason classes | unapproved product |
| UPC / GTIN / UDI-DI | 00661799950527 |
| Lot numbers | 03032021 |
| Expiration dates | 2027-12-31 |
Product
THE ROCK, Male Sexual Performance Enhancement Capsules, 1200 mg, 1 count blister card, Distributed by Steele Productions: Hallandale, FL 33008 UPC 6 61799 95052 7
Reason for recall
Marketed Without an Approved NDA/ANDA: FDA analysis found the product to be tainted with Sildenafil an ingredient found in an FDA approved product for the treatment of male sexual enhancement, making this an unapproved drug.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0158-2024. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.